tradingkey.logo
Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo

Maze Therapeutics Inc

MAZE

15.327USD

+0.427+2.86%
Market hours （ET）Quotes delayed by 15 min
671.27MMarket Cap
LossP/E TTM

Maze Therapeutics Inc

15.327

+0.427+2.86%
OverviewCompanyFinancials
Statements
Income Statement
Balance Sheet
Cash Flow Statement

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2023Q4
FY2023Q3
Total revenue
----
--0.00
--2.50M
----
--0.00
Revenue
----
--0.00
--2.50M
----
--0.00
Operating expenses
--35.40M
28.96%29.73M
5.95%26.73M
--23.05M
--25.23M
R&D expenses
--27.58M
38.46%22.22M
2.05%19.86M
--16.05M
--19.46M
Depreciation, depletion, and amortization
--684.00K
-28.57%705.00K
-21.51%788.00K
--987.00K
--1.00M
Operating profit
---35.40M
-28.96%-29.73M
3.96%-24.23M
---23.05M
---25.23M
Net non-operating interest income (expenses)
Special income (expenses)
----
57.08%-1.64M
---2.65M
---3.83M
--0.00
Income before tax
---32.79M
-12.33%-29.85M
-1.15%-25.03M
---26.58M
---24.75M
Income tax
----
---275.00K
---279.00K
----
--0.00
Equity earnings after tax
----
--39.65M
--22.32M
----
--0.00
Income after tax
---32.79M
-11.30%-29.58M
-0.02%-24.75M
---26.58M
---24.75M
Net income from continuous operations
---32.79M
137.87%10.07M
90.19%-2.43M
---26.58M
---24.75M
Net income attributable to controlling interests
---32.79M
81.54%-4.91M
90.19%-2.43M
---26.58M
---24.75M
Preferred share dividend
----
--14.97M
----
----
----
Net income attributable to common shareholders
---32.79M
81.54%-4.91M
90.19%-2.43M
---26.58M
---24.75M
Basic earnings per share
---1.15
81.54%-0.11
90.19%-0.06
---0.61
---0.57
Diluted earnings per share
---1.15
81.54%-0.11
90.19%-0.06
---0.61
---0.57
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
KeyAI